Pulsar Vascular clinical trials
Acquired by Johnson & Johnson
The registry lists 3 studies whose lead sponsor is Pulsar Vascular. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 6, 2023.
Registry sponsor names on this page
- Pulsar Vascular3 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Johnson & Johnson studies →
- A Study Evaluating the Safety and Effectiveness of the PulseRider® Aneurysm Neck Reconstruction Device Used in Conjunction With Endovascular Coil Embolization in the Treatment of Wide-Neck Bifurcation Intracranial AneurysmTerminatedNCT03383666Phase 3
Sponsor listed in the registry: Pulsar Vascular · Pulsar Vascular — acquired company within the Johnson & Johnson group
- Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and ReconstructionCompletedNCT02312856Not applicable
Sponsor listed in the registry: Pulsar Vascular · Pulsar Vascular — acquired company within the Johnson & Johnson group
- Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial AneurysmsCompletedNCT02435823Not applicable
Sponsor listed in the registry: Pulsar Vascular · Pulsar Vascular — acquired company within the Johnson & Johnson group